---
figid: PMC11083695__cancers-16-01739-g002
figtitle: Reappraisal of the Roles of the Sonic Hedgehog Signaling Pathway in Hepatocellular
  Carcinoma
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11083695
filename: cancers-16-01739-g002.jpg
figlink: /pmc/articles/PMC11083695/figure/F2
number: F2
caption: Non-canonical signaling pathway escapes Patched-1 (PTCH-1), Smoothened (SMO),
  and glioma-associated oncogene (GLI), which are activated via other signaling pathways
  such as guanosine triphosphate hydrolases (GTPase) or Rhodopsin (Rho), phosphoinositide
  3-kinase mammalian target of rapamycin inhibitor (PI3K/mTOR), protein kinase (PKA),
  etc., to allow the target gene expressions. PKA phosphorylates the C-terminus of
  SMO at three sites (transcription factor mothers against decapentaplegic protein—SMAD).
  Phosphoinositide 3-kinase (PI3K) is activated via AKT (protein kinase B, PKB), mammalian
  target of rapamycin inhibitor (mTOR), etc. PI3K interacts with Rho A and Rac for
  the cytoskeleton, and the pleiotropic regular of extracellular virulence factor
  gene (PLCr) acts on sustained calcium 2+ (Ca 2+) flux. Thus, the pathway adjusts
  cytoskeleton, cell migration, angiogenesis, calcium oscillation, etc
papertitle: Reappraisal of the Roles of the Sonic Hedgehog Signaling Pathway in Hepatocellular
  Carcinoma
reftext: Kuo-Shyang Jeng, et al. Cancers (Basel). 2024 May;16(9).
year: '2024'
doi: 10.3390/cancers16091739
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: Sonic hedgehog signaling pathway | hepatocellular carcinoma | cancer stem
  cells | recurrence | resistance
automl_pathway: 0.9495298
figid_alias: PMC11083695__F2
figtype: Figure
redirect_from: /figures/PMC11083695__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11083695__cancers-16-01739-g002.html
  '@type': Dataset
  description: Non-canonical signaling pathway escapes Patched-1 (PTCH-1), Smoothened
    (SMO), and glioma-associated oncogene (GLI), which are activated via other signaling
    pathways such as guanosine triphosphate hydrolases (GTPase) or Rhodopsin (Rho),
    phosphoinositide 3-kinase mammalian target of rapamycin inhibitor (PI3K/mTOR),
    protein kinase (PKA), etc., to allow the target gene expressions. PKA phosphorylates
    the C-terminus of SMO at three sites (transcription factor mothers against decapentaplegic
    protein—SMAD). Phosphoinositide 3-kinase (PI3K) is activated via AKT (protein
    kinase B, PKB), mammalian target of rapamycin inhibitor (mTOR), etc. PI3K interacts
    with Rho A and Rac for the cytoskeleton, and the pleiotropic regular of extracellular
    virulence factor gene (PLCr) acts on sustained calcium 2+ (Ca 2+) flux. Thus,
    the pathway adjusts cytoskeleton, cell migration, angiogenesis, calcium oscillation,
    etc
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - PBK
  - SMO
  - SMOX
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - GLI1
  - GLI2
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - Nucleus
  - Ca2+
---
